The dazzler has the same opinion of kids 5 and over and especially black kids. On the other hand, he loves himself some teacher unions and shitty US public schools.
The dazzler has the same opinion of kids 5 and over and especially black kids. On the other hand, he loves himself some teacher unions and shitty US public schools.
He actually doesn’t support that. He just votes for those who do.
The dazzler has the same opinion of kids 5 and over and especially black kids. On the other hand, he loves himself some teacher unions and shitty US public schools.
He actually doesn’t support that. He just votes for those who do.
Key Points Question Does adding ivermectin, an inexpensive and widely available antiparasitic drug, to the standard of care reduce the risk of severe disease in patients with COVID-19 and comorbidities?
Findings In this open-label randomized clinical trial of high-risk patients with COVID-19 in Malaysia, a 5-day course of oral ivermectin administered during the first week of illness did not reduce the risk of developing severe disease compared with standard of care alone.
Meaning The study findings do not support the use of ivermectin for patients with COVID-19.
Key Points Question Does adding ivermectin, an inexpensive and widely available antiparasitic drug, to the standard of care reduce the risk of severe disease in patients with COVID-19 and comorbidities?
Findings In this open-label randomized clinical trial of high-risk patients with COVID-19 in Malaysia, a 5-day course of oral ivermectin administered during the first week of illness did not reduce the risk of developing severe disease compared with standard of care alone.
Meaning The study findings do not support the use of ivermectin for patients with COVID-19.
Key Points Question Does adding ivermectin, an inexpensive and widely available antiparasitic drug, to the standard of care reduce the risk of severe disease in patients with COVID-19 and comorbidities?
Findings In this open-label randomized clinical trial of high-risk patients with COVID-19 in Malaysia, a 5-day course of oral ivermectin administered during the first week of illness did not reduce the risk of developing severe disease compared with standard of care alone.
Meaning The study findings do not support the use of ivermectin for patients with COVID-19.
n = 500
Enough said about that.
I thought you'd pick up on the fact the study seems to involve people already hospitalized or otherwise under medical care, that is sick people. If I remember right, you guysm take it prophylactically. Regardless, appears to be reasonably well-executed study for what it was intended.
Comments
https://redstate.com/nick-arama/2022/02/15/project-veritas-drops-explosive-fda-video-about-plans-for-future-on-covid-shots-n522905
New York is still masking their children. Democrats are so fucking stupid.
@Swaye this is your state at least.
Give the points and take the French people in this one.
Efficacy of Ivermectin Treatment on Disease Progression Among Adults With Mild to Moderate COVID-19 and Comorbidities
Question Does adding ivermectin, an inexpensive and widely available antiparasitic drug, to the standard of care reduce the risk of severe disease in patients with COVID-19 and comorbidities?
Findings In this open-label randomized clinical trial of high-risk patients with COVID-19 in Malaysia, a 5-day course of oral ivermectin administered during the first week of illness did not reduce the risk of developing severe disease compared with standard of care alone.
Meaning The study findings do not support the use of ivermectin for patients with COVID-19.
Enough said about that.